Literatur
-
1
Birkus G, Hitchcock M J, Cihlar T.
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Antimicrob Agents Chemother.
2002;
46
716-723
-
2
Walker U A, Setzer B, Venhoff N.
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors.
AIDS.
2002;
16
2165-2173
-
3
Walker U A, Bauerle J, Laguno M. et al .
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Hepatology.
2004;
39
311-317
-
4
Walker U A, Bickel M, Lütke-Volksbeck S I. et al .
Relevance of nucleoside analogue reverse transcriptase inhibitor associated genetic and structural effects of mitochondria in adipose tissue of HIV-infected patients.
J Acquir Immune Def Syndr.
2002;
29
117-121
-
5
Walker U A, Langmann P, Miehle N. et al .
Beneficial effects of oral uridine in mitochondrial toxicity.
AIDS.
2004;
18
1085-1086
-
6
Walker U A, Venhoff N.
Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
Antivir Ther.
2005;
10 Suppl 2
M117-M123
Prof. Dr. J. K. Rockstroh
Medizinische Klinik und Poliklinik I · Universitätsklinikum Bonn
Sigmund-Freud-Str. 25 · 53105 Bonn
Email: rockstroh@uni-bonn.de
